Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease

被引：16
|
作者：
Spiegel, Joerg [1 ]
机构：
[1] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany
来源：
PARKINSONS DISEASE | 2010年 / 2010卷
关键词：
CARDIAC SYMPATHETIC DENERVATION; I-123-MIBG SCINTIGRAPHY; LEWY BODIES; DIFFERENTIAL-DIAGNOSIS; CLINICAL-DIAGNOSIS; METAIODOBENZYLGUANIDINE; DEGENERATION; DYSFUNCTION; PHEOCHROMOCYTOMA; ACCURACY;
D O I：
10.4061/2010/295346
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Myocardial MIBG scintigraphy is established in the diagnosis and differential diagnosis of Parkinson's disease (PD). Numerous studies address the pathophysiological impact of myocardial MIBG scintigraphy: the myocardial MIBG uptake correlates with the clinical phenotype of PD; the background of this phenomenon is unclear. Furthermore MIBG scintigraphy enables to study the extracranial Lewy body type-degeneration. In combination with cerebral dopamine transporter imaging, MIBG scintigraphy allows to correlate cerebral and extracranial Lewy body type-degeneration in PD.
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Correlation between odor identification and MIBG myocardial scintigraphy in patients with Parkinson's disease: Preliminary results
    Bartolomei, L.
    Salgarello, M.
    Pontarin, M.
    L'Erario, R.
    Cecchin, D.
    MOVEMENT DISORDERS, 2009, 24 : S318 - S318
  • [22] Cardiac MIBG scintigraphy abnormalities and the time course of Parkinson's disease
    Aburakawa, Y.
    Kimura, T.
    Fujiwara, K.
    Katayama, T.
    Makita, Y.
    Enomoto, H.
    Kuroda, K.
    Aizawa, H.
    Yahara, O.
    JOURNAL OF NEUROLOGY, 2007, 254 : 122 - 122
  • [23] FP-CIT and MIBG scintigraphy in early Parkinson's disease
    Spiegel, J
    Möllers, MO
    Jost, WH
    Fuss, G
    Samnick, S
    Dillmann, U
    Becker, G
    Kirsch, CM
    MOVEMENT DISORDERS, 2005, 20 (05) : 552 - 561
  • [24] Myocardial 123I-MIBG scintigraphy correlates with phenotypes of Parkinson's disease rather than disease severity
    Araki, K.
    Shibayama, H.
    Katada, F.
    Sato, S.
    Fukutake, T.
    MOVEMENT DISORDERS, 2010, 25 (07) : S289 - S289
  • [25] The combination of the MIBG myocardial scintigraphy and DATSPECT contributes to the diagnosis of Parkinson's disease and other related disorders.
    Tada, S.
    Ohtsubo, H.
    Yamanishi, Y.
    Miyaue, N.
    Ando, R.
    Yabe, H.
    Nishikawa, N.
    Nagai, M.
    Miyagawa, M.
    Nomoto, M.
    MOVEMENT DISORDERS, 2017, 32
  • [26] Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson's Disease
    Mizukami, Heisuke
    Shiraishi, Makoto
    Hino, Sakae
    Kaburagi, Mayumi
    Matsumoto, Hirofumi
    Hagiwara, Yuta
    Yamano, Yoshihisa
    BRAIN SCIENCES, 2024, 14 (06)
  • [27] Cardiac MIBG scintigraphy can predict prognosis of patients with Parkinson's disease
    Orimo, S.
    Azuma, L.
    Takahashi, M.
    Sakamoto, M.
    Inaba, A.
    MOVEMENT DISORDERS, 2013, 28 : S55 - S56
  • [28] Evaluation of MIBG scintigraphy in the movement disorder society Parkinson's Disease criteria
    Ikenoshita, S.
    Ikeda, T.
    Nakahara, K.
    Masuda, T.
    Yamashita, S.
    Ando, Y.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 260 - 260
  • [29] MIBG scintigraphy in Parkinson's disease with and without LRRK2 mutations
    Masso, J. F. Marti
    Martinez, J. Ruiz
    Bolano, M. J.
    Gorostidi, A.
    Marras, C.
    de Munain, A. J. Lopez
    MOVEMENT DISORDERS, 2008, 23 (01) : S254 - S255
  • [30] 0098-I-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: A case series study
    Yamada, Akane
    Murakami, Takenobu
    Iikuni, Yoichiro
    Morimatsu, Akeshi
    Shirata, Akiko
    Ito, Hiroshi
    Ugawa, Yoshikazu
    Yamane, Kiyomi
    MOVEMENT DISORDERS, 2016, 31 : S23 - S23
12345